Sign in to view content

Brolucizumab: Will it Make a Differance

Andrew P. Schachat, MD

Video
Published 2018

Related

TIE2, VEGF, and Integrin Receptor Interplay and its Role in Retinal Disease
Peter K. Kaiser, MD FASRS
Updates from the Field
2020
Anti-VEGF Injection Prior Authorization Impacts on Retina Practices
Sabin Dang, MD
Updates from the Field
2022
Predictors of Post-injection Endophthalmitis: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019

Category: AMD-Neovascular

See more